Quantitative structure-activity relationships for organophosphates binding to trypsin and chymotrypsin

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 74, Issue 1, 2011, Pages 1-23

  Ruark, Christopher D ^a   Hack, C Eric ^a   Robinson, Peter J ^a   Gearhart, Jeffery M ^a  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN; ORGANOPHOSPHATE PESTICIDE; TRYPSIN;

ARTICLE; COMPUTER PROGRAM; GEOMETRY; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTUM MECHANICS; STATIC ELECTRICITY; THERMODYNAMICS; VALIDITY;

ANIMALS; CHYMOTRYPSIN; ENZYME INHIBITORS; HUMANS; HYDROGEN BONDING; MODELS, CHEMICAL; PHOSPHORIC ACID ESTERS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS; STATIC ELECTRICITY; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPSIN;

EID: 78649890548     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2010.501716     Document Type: Article

References (80)

1. Ahmad, S. 1970. The recovery of esterases in organophosphate-treated housefly (Musca Domestica L.). Comp. Biochem. Physiol. 33:579-586.
2. Anson, M. L., and Mirsky, A. E. 1934. The equilibrium between active native trypsin and inactive denatured trypsin. J. Gen. Physiol. 17:393-398.
3. Aroniadou-Anderjaska, V., Figueiredo, T. H., Apland, J. P., Qashu, F., and Braga, M. F. M. 2009. Primary brain targets of nerve agents: The role of the amygdale in comparison to the hippocampus. Neurotoxicology 30: 772-776.
4. Bajgar, J., Fusek, J., Kassa, J., Jun, D., Kuca, K., and Hajek, P. 2008. An attempt to assess functionally minimal acetylcholinesterase activity necessary for survival of rats intoxicated with nerve agents. Chem. Biol. Interact. 175:281-285.
5. Balls, A. K., and Jansen, E. F. 1952. Stoichiometric inhibition of chymotrypsin. Adv. Enzymol. 13:321-343.
6. Barratt, M. D. 1998. Integrating computer prediction systems with in vitro methods towards a better understanding of toxicology. Toxicol. Lett. 102:102-103.
7. Bhongade, B., and Gadad, A. 2004. 3D-QSAR CoMFA/CoMSIA studies on urokinase plas-minogen activator (uPA) inhibitors: A strategic design in novel anticancer agents. Bioorg. Med. Chem. 12:2797-2805.
8. Bhongade, B., Gouripur, V. V., and Gadad, A. K. 2005. 3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: A comparative selectivity analysis. Bioorg. Med. Chem. 13: 2773-2782.
9. Blaauboer, B. J. 2003. The integration of data on physico-chemical properties, in vitro-derived toxicity data and physiologically based kinetic and dynamic as modelling a tool in hazard and risk assessment. A commentary. Toxicol. Lett. 138:161-171.
10. Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., and Karplus, M. 1983. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4: 187-217.
11. Chambers, J. L., and Stroud, R. M. 1977. Difference fourier refinement of the structure of DIP-trypsin at 1.5A with a minicomputer technique. Acta Crystallogr. Sect. B 33:1824-1837.
12. Coi, A., Massarella, I., Murgia, L., Saraceno, M., Calderone, V. and Bianucci, A. M. 2006. Prediction of hERG potassium channel affinity by the CODESSA approach. Bioorg. Med. Chem. 14:3153-3159.
13. Conolly, R. B., and Andersen, M. E. 1991. Biologically based pharmacodynamic models: Tools for toxicological research and risk assessment. Annu. Rev. Pharmacol. Toxicol. 31:503-523.
14. Davies, B., Kearns, I. R., Ure, J., Davies, C. H., and Lathe, R. 2001. Loss of hippocampal ser-ine protease BSP1/Neuropsin predisposes to global seizure activity. J. Neurosci. 21:6993-7000.
15. Ekici, O. D., Paetzel, M., and Dalbey, R. E. 2008. Unconventional serine proteases: Variations on the catalytic Ser/His/Asp triad configuration. Protein Sci. 17:2023-2037.
16. Frier, B.M., Adrian, T.E., Saunders, J.H.B., and Bloom, S.R. 1980. Serum trypsin concentration and pancreatic trypsin secretion in insulin-dependent diabetes mellitus. Clinica Chimica Acta. 105: 297-300.
17. Gearhart, J. M., Jepson, G. W., Clewell, H. J. III, Andersen, M. E., and Conolly, R. B. 1990. Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropy-lfluorophosphate. Toxicol. Appl. Pharmacol. 106:295-310.
18. Gearhart, J. M., Jepson, G. W., Clewell III, H. J., Andersen, M. E., and Conolly, R. B. 1994. Physiologically based phar-macokinetic model for the inhibition of acetylcholinesterase by organophosphate esters. Environ. Health Perspect. 102(suppl. 11):51-60.
19. Gingrich, M., and Traynelis, S. 2000. Serine proteases and brain damage-Is there a link? Trends Neurosci. 3:399-407.
20. Golbraikh, A. and Tropsha, A. 2002. Beware of q2!. J. Mol. Graphics Modell. 20:269-276.
21. Hansch, C., and Deutsch, E. W. 1966. The use of substituent constants in the study of structure-activity relationships in cholinesterase inhibitors. Biochim. Biophys. Acta 126:117-128.
22. Hansch, C., and Leo, A. 1979. Substituent constants for correlation analysis in chemistry and biology. New York: John Wiley & Sons.
23. Hansch, C., Leo, A., Mekapati, S. B., and Kurup, A. 2004. QSAR and ADME. Bioorg. Med. Chem. 12:3391-3400.
24. Hawkins, D. M. 2004. The problem of over-fitting. J. Chem. Inf. Comput. Sci. 44: 1-12.
25. Holmuhamedov, E. L., Kholmoukhamedova, G. L., and Baimuradov, T. B. 1996. Non-cholinergic toxicity of organophosphates in mammals: Interaction of ethaphos with mitochondrial functions. J. Appl. Toxicol. 16: 475-481.
26. Ivanciuc, O. 1997. CODESSA version 2.13 for Windows. J. Chem. Inf. Comput. Sci. 37:405-406.
27. Jinsong, Z., Bin, W., Zhaoxia, D., Xiaodong, W., and Lingren, W. 2004. 3D-quantitative structure-activity relationship study of organophosphate compounds. Chin. Sci. Bull. 49:240-245.
28. Joosen, M. J., Jousma, E., van den Boom, T. M., Kuijpers, W. C., Smit, A. B., Lucassen, P. J., and van Helden, H. P. 2009. Long-term cognitive deficits accompanied by reduced neurogenesis after soman poisoning. Neurotoxicology. 30: 72-80.
29. Kamgang, E., Peyret, T., and Krishnan, K. 2008. An integrated QSPR-PBPK modelling approach for in vitro-in vivo extrapolation of pharmacokinetics in rats. SAR QSAR Environ. Res. 19:669-680.
30. Katritzky, A. R., Wang, Y., Sild, S., and Tamm, T. 1998. QSPR studies on vapor pressure, aqueous solubility, and the prediction of water-air partition coefficients. J. Chem. Inf. Comput. Sci. 38:720-725.
31. Katritzky, A. R., Perumal, S., Petrukhin, R., and Kleinpeter, E. 2001. CODESSA-based theoretical QSPR model for hydantoin HPLC-RT lipophilicities. J. Chem. Inf. Comput. Sci. 41:569-574.
32. Katritzky, A. R., Kuanar, M., Fara, D. C., Karelson, M., Acree, W. E., Jr., Solov'ev, V. P., and Varnek, A. 2005. QSAR modeling of blood:air and tissue:air partition coefficients using theoretical descriptors. Bioorg. Med. Chem. 13:6450-6463.
33. 50 of aquatic toxicities for Daphnia magna. J. Toxicol. Environ. Health A 72:1181-1190.
34. Kavlock, R. J., and Setzer, R. W. 1996. The road to embryologically based dose-response models. Environ. Health Perspect. 104(suppl. 1):107-121.
35. Kier, L. 1985. A shape index from molecular graphs. Quant. Struct. Act. Relat. 4: 109-116.
36. Kier, L., and Hall, L. 1986. Molecular connectivity in structure-activity analysis. London: John Wiley.
37. Knaak, J. B., Dary, C. C., Power, F., Thomson, C. B., and Blancato, J. N. 2004. Physicochemical and biological data for the development of predictive organophospho-rus pesticide QSARs and PBPK/PD models for human risk assessment. Crit. Rev. Toxicol. 34:143-207.
38. Kossiakoff, A.1984. Use of the neutron diffraction h/d exchange technique to determine the conformational dynamics of trypsin. Basic Life Sci. 27:281-304.
39. Kovach, I. 1988. Structure and dynamics of serine hydrolase- organophosphate adducts. Enzyme Inhib. 2:199-208.
40. Langenberg, J. P., Dijk, C. V., Sweeney, R. E., Maxwell, D. M., De Jong, L. P. A., and Benschop, H. P. 1997. Development of a physiologically based model for the toxicokinetics of C( ±)P( ±)-soman in the atropinized guinea pig. Arch. Toxicol. 71:320-331.
41. Leo, A., Hansch, C., and Elkins, D. 1971. Partition coefficients and their uses. Chem. Rev. 71: 525-616.
42. Lockridge, O. 2008. Mass spectrometry to identify new biomarkers of nerve agent exposure. U.S. Army Medical Research and Materiel Command, Fort Detrick, MD. ADA483399.
43. Lowe, E. R., Rick, D. L., West, R. J., and Bartels, M. J. 2006. The evaluation of quantitative structure-property relationship predictions of tissue: Blood partition coefficients of highly lipophilic chemicals. Drug Metab. Rev. 38:78.
44. Makhaeva, G. F., Aksinenko, A. Y., Sokolov, V. B., Serebryakova, O. G., and Richardson, R. J. 2009. Synthesis of organophosphates with fluorine-containing leaving groups as serine esterase inhibitors with potential for Alzheimer disease therapeutics. Bioorg. Med. Chem. Lett. 19:5528-5530.
45. Metcalf, R., and Metcalf, R. 1984. Steric, electronic, and polar parameters that affect the toxic actions of O-alkyl, O-phenyl phos-phonothionate insecticides. Pestic. Biochem. Physiol. 22:169-177.
46. Millard, C. B., Kryger, G., Ordentlich, A., Greenblatt, H. M., Harel, M., Raves, M. L., Segall, Y., Barak, D., Shafferman, A., Silman, I., and Sussman, J. L. 1999. Crystal structures of aged phosphonylated acetyl-cholinesterase: Nerve agent reaction products at the atomic level. Biochemistry 38:7032-7039.
47. Movsesyan, V. A., Yakovlev, A. G., Fan, L., and Faden, A. I. 2001. Effect of ser-ine protease inhibitors on posttraumatic brain injury and neuronal apoptosis. Exp. Neurol. 167:366-375.
48. Murray, A., Rathbone, A. J., and Ray, D. E. 2005. Novel protein targets for organophos-phorus pesticides in rat brain. Environ. Toxicol. Pharmacol. 19:451-454.
49. Northrop, J. H., Kunitz, M., and Herriott, R. M. 1948. Crystalline enzymes. New York: Columbia University Press.
50. Ooms, A. J. J. 1961. The reactivity of organic phosphor combinations in regards to a number of esterases. Rijks Universiteit, Groningen, the Netherlands.
51. Ooms, A. J. J., and van Dijk, C. 1966. The reaction of organophosphorus compounds with hydrolytic enzymes. III. The inhibition of α-chymotrypsin and trypsin. Biochem. Pharmacol. 15:1361-1377.
52. Pancetti, F., Olmos, C., Dagnino-Subiabre, A., Rozas, C., and Morales, B. 2007. Noncholinesterase effects induced by organophosphate pesticides and their relationship to cognitive processes: Implication for the action of acylpeptide hydrolase. J. Toxicol. Environ. Health B 10:623-630.
53. Pen, J., Bolks, G. J., Hoeksema-Du Pui, M. L. L., and Beintema, J. J. 1990. Serine esterases: structural conservation during animal evolution and variability in enzymic properties in the genus Drosophilia. Genetica 81:125-131.
54. Poet, T. S., Kousba, A. A., Dennison, S.L., and Timchalk, C. 2004. Physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus pesticide diazi-non. Neurotoxicology 25:1013-1030.
55. Poulin, P., and Krishnan, K. 1995. An algorithm for predicting tissue:blood partition coefficients of organic chemicals from n-octanol:water partition coefficient data. J. Toxicol. Environ. Health 46:117-129.
56. Puente, X. S., Sanchez, L. M., Gutierrez-Fernandez, A., Velasco, G., and Lopez-Otin, C. 2005. A genomic view of the complexity of mammalian protelytic systems. Biochem. Soc. Transact. 33:331-334.
57. Quistad, G., and Casida, J. 2000. Sensitivity of blood-clotting factors and digestive enzymes to inhibition by organophosphorus pesticides. J. Biochem. Mol. Toxicol. 14:51-56.
58. Raevsky, O. A., Chistyakov, V. V., Agabekyan, R. S., Sapegin, A. M., and Zefirov, N. S. 1990. Formation of a model of the interrelationship between the structure of organophosphorus compounds and their capacity for inhibiting cholinesterases. Bioorg. Khim. 16:1509-1522.
59. Rawlings, N., and Barrett, A. 1994. Families of serine peptidases. Methods Enzymol. 244:19-61.
60. Raveh, L., Weissman, B. A., Cohen, G., Alkalay, D.,Rabinovitz,I.,Sonego, H.,andBrandeis,R. 2002. Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction. Neurotoxicology. 23:7-17.
61. Reddy, S., Bibby, N.J., Smith, P.A., and Elliott, R.B. 1985. Rat trypsin: Purification, radioim-munoassay and age-related serum levels in normal and spontaneously diabetic BB Wistar rats. Aust. J. Exp. Biol. Med. Sci. 63: 667-681.
62. Richards, P. G., Johnson, M. K., and Ray, D. E. 2000. Identification of acylpeptide hydrolase as a sensitive site for reaction with organophosphorus compounds and a potential for cognitive enhancing drugs. Mol. Pharmacol. 58:577-583.
63. Richardson, R. 1992. Interactions of organo-phosphorus compounds with neurotoxic esterase. In Organophosphates- Chemistry, fate, and effects, eds. J. E. Chambers and P. E. Levi, pp. 299-323. San Diego, CA: Academic Press.
64. Rucker, C., Rucker, G., and Meringer, M. 2007. Y-Randomization and its variants in QSPR/QSAR. J. Chem. Inf. Model. 47:2345-2357.
65. 32-labeled isopropyl methylphosphonofluoridate-inactivated trypsin. J. Biol. Chem. 1: 185-192.
66. Setzer, W. R., Lau, C., Mole, M. L., Copeland, M. F., Rogers, J. M., and Kavlock, R. J. 2001. Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: A mathematical construct. Toxicol. Sci. 59: 49-58. (Pubitemid 32117980)
67. Sultatos, L. 1990. A physiologically based phar-macokinetic model of parathion based on chemical-specific parameters determined in vitro. J. Am. Coll. Toxicol. 9:611-619.
68. Sumathy, K. 2007. "Chemical descriptors" from QSARWorld-A strand life sciences web resource. http://www.qsarworld.com/ insilico-chemistry-chemical-descriptors.php.
69. Sweeney, R. E., Langenberg, J. P., and Maxwell,D. M. 2006. Aphysiologically based pharmacokinetic (PB/PK) model for multiple exposure routes of soman in multiple species. Arch. Toxicol. 80:719-731.
70. Taylor, P., Wong, L., Radic, Z., Tsigelny, I., Bruggemann, R., Hosea, N. A., and Berman, H. A. 1999. Analysis of choline-sterase inactivation and reactivation by systematic structural modification and enan-tiomeric selectivity. Chem. Biol. Interact. 119-120:3-15.
71. Timchalk, C., Nolan, R. J., Mendrala, A. L., Dittenber, D. A., Brzak, K. A., and Mattsson, J. L. 2002. A physiologically based pharma-cokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans. Toxicol. Sci. 66:34-53.
72. Timchalk, C., Kousba, A., and Poet, T. S. 2007. An age-dependent physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus insecticide chlor-pyrifos in the preweanling rat. Toxicol. Sci. 98:348-365.
73. Van Der Merwe, D., Brooks, J. D., Gehring, R., Baynes, R. E., Monteiro-Riviere, N. A., and Riviere, J. E. 2006. A physiologically based pharmacokinetic model of organophosphate dermal absorption. Toxicol. Sci. 89:188-204.
74. Vedani, A., Dobler, M., and Lill, M. A. 2005. Combining protein modeling and 6D-QSAR. Simulating the binding of structurally diverse ligands at the estrogen receptor. J. Med. Chem. 48:3700-3703.
75. Vilceanu, R., Chiriac, A., Szabadai, Z., and Simon, Z. 1977. Structure-activity correlations for the toxicity of organic phosphorus compounds of the Schrader type. Seria Stiinte Fizice-Chim. 15:61-68.
76. Voet, D., and Voet, J. 2004 Biochemistry, 3rd ed. New York: John Wiley & Sons.
77. Wang, J., Gu, J., and Leszczynski, J. 2006. Phosphonylation mechanisms of sarin and acetylcholinesterase: A model DFT study. J. Phys. Chem. B 110:7567-7573.
78. Yang, R. S., Thomas, R. S., Gustafson, D. L., Campain, J., Benjamin, S. A., Verhaar, H. J., and Mumtaz, M. M. 1998. Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling. Environ. Health Perspect. 106: 1385-1393
79. Yang, M. Zhou, L., Zuo, Z., Mancera, R., Song, H., Tang, X., Ma, X. 2009. Docking study and three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses of transforming growth factor-B type I receptor kinase inhibitors. QSAR Comb. Sci. 28:1300-1308.
80. Zhang, Y., Kua, J., and McCammon, J. A. 2002. Role of the catalytic triad and oxyanion hole in acetylcholinesterase catalysis: An ab initio QM/MM study. J. Am. Chem. Soc. 124:10572-10577.